Has Charles Drummond, MD received payments from drug or device companies?

Yes. Drug and device makers reported $38,094 in general payments to Charles Drummond, MD across 304 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Charles Drummond, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Charles Drummond, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Charles Drummond, MD

Vascular Surgery · Tullahoma, TNNPI 1609891803

Payments from drug & device makers

What this record shows

This record is dominated by other: $31,057 of the $38,094 with a category attached, or 81.5%. 48 manufacturers reported payments, led by Convatec Inc. at 51.0% of the total. Reporting peaked in 2024 at $29,817 and has fallen 94.4% since, to $1,676 in 2025.

$38,094in general payments, 2019–2025

Across 304 payments — averaging $125.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Convatec Inc.$19K
Angiodynamics, Inc.$12K
Organogenesis Inc.$776
Smith+Nephew$659
Medtronic$644
Cardiovascular Systems Inc.$490
plus $4K from 42 others

What the payments were for

Speaking & faculty fees$790%
Travel & lodging$3691%
Food & beverage$6,59017%
Other$31,05782%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Convatec Inc.	5	$19,416
Angiodynamics, Inc.	19	$12,310
Organogenesis Inc.	36	$776
Smith+Nephew	26	$659
Medtronic(2 entities)	13	$644
Cardiovascular Systems Inc.	33	$490
Kerecis Limited	12	$443
Johnson & Johnson	23	$354
Endologix LLC	1	$289
Lemaitre Vascular, Inc.	14	$253
AbbVie(2 entities)	15	$242
Triad Life Sciences Inc.	13	$203
KCI USA, Inc.	10	$191
Paratek Pharmaceuticals, Inc.	10	$190
Progenacare Global, LLC	3	$162
Melinta Therapeutics, LLC	9	$139
Biocomposites Inc	1	$118
Aroa Biosurgery Incorporated	2	$107
Urgo Medical North America, LLC	3	$101
Reprise Biomedical, Inc.	5	$100
Polynovo North America LLC	3	$87
Advanced Oxygen Therapy Inc.	6	$79
Solventum Corporation	3	$60
Acelrx Pharmaceuticals, Inc.	3	$58
Tactile Systems Technology Inc	4	$57
Cordis US CORP.	2	$55
Acera Surgical, Inc.	2	$42
Osiris Therapeutics Inc.	2	$41
Amgen	2	$38
Medline Industries LP	2	$33
Cagent Vascular Inc	1	$31
Kowa Pharmaceuticals America, Inc.	2	$28
Cumberland Pharmaceuticals, Inc.	2	$27
Misonix Inc	2	$25
Abbott	1	$24
Reflow Medical Inc	2	$22
Bard Peripheral Vascular, Inc.	1	$21
Cardiva Medical, Inc.	1	$20
Hartmann USA, Inc.	1	$20
Sun Pharmaceutical Industries Inc.	1	$19
Bioventus LLC	1	$19
Pfizer	1	$18
Stryker	1	$16
Nabriva Therapeutics, PLC	1	$15
Integra Lifesciences Corporation	1	$15
Medela LLC	1	$14
Cashflow Solutions, LLC	1	$13
Davol Inc.	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$38,094 in reported general payments places this provider in the 85th percentile of 117 vascular surgery providers in Tennessee.

See all vascular surgery providers in Tennessee →

Medicare billing

Part B allowed, 2024

$1,797,839

Medicare patients

239

Services billed

2,895

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	23	$159

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Tullahoma

Daniel ClairNashville$993K
Anton Dias PereraGermantown$832K
Bryan FisherHendersonville$417K
Christopher LesarChattanooga$311K
Billy KimMount Juliet$140K
William HarrisChattanooga$122K
Mark FugateChattanooga$100K
Heesuk YoonJohnson City$95K
Scott StevensKnoxville$53K
Robert AllenKingsport$51K

See the full list for Tennessee →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →